Ecuador | Imports and Exports | World | Pharmaceutical products | Value (US$) and Value Growth, YoY (%) | 2012 - 2023
The value of exports of commodity group 30 "Pharmaceutical products" from Ecuador totalled $ 34 million in 2023. Sales of commodity group 30 from Ecuador decreased by 13.3% in value terms compared to 2022. exports of commodity group 30 "Pharmaceutical products" decreased by $ 5.25 million (cumulative exports of commodity group 30 from Ecuador amounted $39 million in 2022)
Exports of commodity group 30 "Pharmaceutical products" amounted to 0.109% of total exports from Ecuador (cumulative merchandise exports from Ecuador totalled $ 31 billion in 2023). The share of commodity group 30 in total exports from Ecuador decreased by 0.001 p.p. compared to 2022 (it was 0.111% in 2022 and cumulative exports from Ecuador were equal to $ 35 billion).
Where does Ecuador export Pharmaceutical products?
Top export destinations of "Pharmaceutical products" from Ecuador in 2023:
- Panama with a share of 19.7% (6.72 million US$)
- Colombia with a share of 17.4% (5.93 million US$)
- Chile with a share of 16.5% (5.64 million US$)
- Peru with a share of 13.2% (4.52 million US$)
- Bolivia with a share of 6.46% (2.2 million US$)
- Guatemala with a share of 5.58% (1.89 million US$)
- Dominican Republic with a share of 5.32% (1.8 million US$)
- Brazil with a share of 3.69% (1.25 million US$)
- Mexico with a share of 3.16% (1.07 million US$)
- Uruguay with a share of 2.01% (686 thousand US$)
Exports structure of 30 - Pharmaceutical products - from Ecuador in 2023 represented by the following main commodity groups:
- 90% (30 million US$): 3004 - Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale
- 4.18% (1.42 million US$): 3002 - Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc
- 3.64% (1.23 million US$): 3006 - Pharmaceutical goods specified in Note 4 to this Chapter.
- 0.952% (324 thousand US$): 3005 - Wadding, gauze, bandages and similar articles (for example, dressings, adhesive plasters, poultices), impregnated or coated with pharmaceutical substances or put up in forms or packings for retail sale for medical, surgical, dental or veterinary purposes.
- 0.597% (203 thousand US$): 3003 - Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses, not put up in measured doses or in forms or packings for retail sale
- 0% (20 US$): 3001 - Glands, organs (extracts, secretions thereof) for organo-therapeutic uses, dried, powdered or not; heparin and its salts; other human or animal substances for therapeutic or prophylactic uses n.e.s.
The value of imports of commodity group 30 "Pharmaceutical products" to Ecuador totalled $ 1.33 billion in 2023. Sales of commodity group 30 to Ecuador went up by 2.51% compared to 2022: imports of commodity group 30 "Pharmaceutical products" went up by $ 32 million (the value of imports of commodity group 30 to Ecuador was equal to $1.29 billion in 2022)
Imports of commodity group 30 "Pharmaceutical products" accounted for 4.31% of total import flow to Ecuador (in 2023, total imports to Ecuador amounted to $ 30 billion). The share of commodity group 30 in total imports to Ecuador increased by 0.379 p.p. compared to 2022 (it was 3.93% in 2022 and cumulative imports to Ecuador were equal to $ 33 billion).
Where does Ecuador import Pharmaceutical products from?
Top trading partners (import of "Pharmaceutical products") of Ecuador in 2023:
- Colombia with a share of 12.8% (170 million US$)
- USA with a share of 9.72% (129 million US$)
- Germany with a share of 9.03% (120 million US$)
- Mexico with a share of 7.34% (97 million US$)
- Argentina with a share of 6.21% (82 million US$)
- India with a share of 5.77% (76 million US$)
- Switzerland with a share of 4.26% (56 million US$)
- Chile with a share of 3.99% (53 million US$)
- Spain with a share of 3.96% (52 million US$)
- Italy with a share of 3.33% (44 million US$)
Imports structure of 30 - Pharmaceutical products - to Ecuador in 2023 represented by the following main commodity groups:
- 75% (1 billion US$): 3004 - Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale
- 19.1% (255 million US$): 3002 - Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc
- 3.84% (51 million US$): 3006 - Pharmaceutical goods specified in Note 4 to this Chapter.
- 1.1% (14.6 million US$): 3005 - Wadding, gauze, bandages and similar articles (for example, dressings, adhesive plasters, poultices), impregnated or coated with pharmaceutical substances or put up in forms or packings for retail sale for medical, surgical, dental or veterinary purposes.
- 0.382% (5.09 million US$): 3003 - Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses, not put up in measured doses or in forms or packings for retail sale
- 0.077% (1.03 million US$): 3001 - Glands, organs (extracts, secretions thereof) for organo-therapeutic uses, dried, powdered or not; heparin and its salts; other human or animal substances for therapeutic or prophylactic uses n.e.s.
